European Journal of Dermatology
MENULeonine facies as the initial manifestation of CD56+ myeloid sarcoma Volume 31, numéro 1, January-February 2021
Illustrations
1 School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
2 Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
3 Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
4 Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
5 Department of Neurology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
6 Neuroscience Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan
7 Department of Neurology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
* These authors contributed equally.
- DOI : 10.1684/ejd.2021.3977
- Page(s) : 114-5
- Année de parution : 2021
Myeloid sarcoma (MS) is a rare extramedullary tumour, composed of myeloblasts or immature myeloid cells, occurring most often in the skin, soft tissues and bones [1]. Cluster of differentiation (CD) 56 is not a dominant marker of MS [2], and CD56+ MS may be associated with a poor prognosis [3]. The manifestation of leonine facies resembles the face of a lion and is seen in multiple conditions including mycosis fungoides, lepromatous leprosy [4] and haematological neoplasms. Here, we report the first [...]